MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Keiretsu Forum
Industry: Silicon Valley, California
Revolution Medicines, Inc. (Nasdaq:RVMD)*
Finance & Acquisitions: Revolution Medicine
Warp Drive Bio
Parents
Architects: Biotechnology_Genomics, Multiomics
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
Companies: Acquired_(M&A)
Finance & Acquisitions: Ginkgo Bioworks
Finance & Acquisitions: Revolution Medicine
Ginkgo Bioworks _Crunchbase company_financials
Industry: Massachusetts
Children
2012: Warp Drive Bio Launches With $125 Million from Third Rock Ventures, Greylock, Sanofi (2012)
2012: Warp Drive Bio Launches With $125M from Third Rock, Greylock, Sanofi (2012)
2018: Six years after a spectacular debut, Warp Drive Bio is powering down and handing its 'undruggable' ambitions over to Revolution
Boston, Massachusetts
Cambridge, Massachusetts
CEO: Gregory Verdine, Ph.D., Parabilis Medicines, LifeMine Therapeutics (2022)
Customized search queries that enable hidden natural products to be revealed on the basis of their distinctive genomic signature.
Founded 2011
Key to the Warp Drive Bio approach is the company's proprietary "genomic search engine"
Particularly those that are currently considered "undruggable."
The company was founded by renowned scientist Dr. Gregory Verdine, along with Dr. George Church and Dr. James Wells.
Warp Drive Bio is leading the reemergence of natural products in the era of genomics to create breakthrough therapies targeting critical biological pathways